Daiichi Life raises domestic equity sales plan to about ¥900bn as higher rates cut solvency ratio
Higher yields are widening the investment spread at Daiichi Life Group's main insurer, but the group's solvency ratio slipped to about 211% on surrender risk, and its full-year domestic equity sales estimate rose to about ¥900bn.